Reuters logo
UK switches over to Merck, Sanofi HPV vaccine
November 24, 2011 / 4:21 PM / 6 years ago

UK switches over to Merck, Sanofi HPV vaccine

LONDON, Nov 24 (Reuters) - Britain will switch to using the HPV vaccine Gardasil, supplied by Sanofi Pasteur MSD, from September next year, instead of GlaxoSmithKline’s rival product Cervarix, the government said on Thursday.

The decision follows a competitive tendering exercise that was won by the joint venture operation of Merck & Co and Sanofi.

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below